CureVac strikes COVID-19 vaccine alliance deal with Bayer -Bild
FRANKFURT (Reuters) - German biotech firm CureVac has agreed to an alliance with drugmaker Bayer to get global support in seeking approval for its experimental COVID-19 vaccine and for distribution, the daily Bild reported.
